THE
VA L U E OF
VA C C I N E S ã¯ã¯ãã³ã® 䟡 å€
2 T H E VA LU E O F VACC I N ES
ç®æ¬¡
ãã¯ã¯ãã³ã®äŸ¡å€ãå·»é æšæ¶
âââââââââââââââââââââââââââââââ
04
ââââââââââââââââââââââââââââââââââ
06
â âââââââââââââââââââââââââââââââââââââââââââ
08
The Value of Vaccines ã¯ããã«
ⶠã¯ã¯ãã³ã®å ¬è¡è¡çå šè¬ã®äŸ¿çãšè²»çšé¢ã§ã®äŸ¿ç ....................................................................................................................... 08 â· ã¯ã¯ãã³æ¥çš®ã¯ãã®ä»ã®äºé²å»çãžã®ã¢ã¯ã»ã¹ãæäŸãã ......................................................................................................... 11 âž ã¯ã¯ãã³æ¥çš®ã®å®å šæ§ãšãªã¹ã¯ ........................................................................................................................................................... 12
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
â ââââââââââââââââââââââââââââââ
14
ⶠææçã«ãã瀟äŒçæ倱ãé²ã ......................................................................................................................................................... 14 ⷠ矩åèŠå®ããåªå矩åèŠå®ãž ............................................................................................................................................................. 14 âž ãåå¥ãæ¥çš®ã®å眪 ................................................................................................................................................................................ 15 â¹ é«éœ¢å瀟äŒãè¿ã㊠.............................................................................................................................................................................. 17 ⺠æ°èã»åèææçãšã¯ã¯ãã³ã»ã®ã£ãã ............................................................................................................................................ 17 â» æ¹æ£äºé²æ¥çš®æ³ãšäºé²æ¥çš®åºæ¬èšç»ã®çå® ................................................................................................................................... 18 ⌠ä»åŸã®æ¥æ¬ã«ãããã¯ã¯ãã³ã®äŸ¡å€ãšã¯ ........................................................................................................................................... 19
ã¯ã¯ãã³ãäžå¿ã«ã äºé²å»åŠã®é²å±ã倧ãã«æåŸ ã§ãã
ââââââââââââââââââââââââ
20
å·åŽåžå®å šç 究ææé·ã»åçç§åŠå¯©è°äŒäºé²æ¥çš®ã»ã¯ã¯ãã³åç§äŒäŒé· å²¡éš ä¿¡åœŠ
T H E VA LU E O F VACC I N ES 3
ãã¯ã¯ãã³ã®äŸ¡å€ãå·»é æšæ¶ ããåœã§ã¯ãå®ææ¥çš®ã¯ã¯ãã³ã®çš®é¡ã欧米
ããã«ãã¯ã¯ãã³ãå«ãå» è¬åã®æäžã«ã¯ã
è«žåœã«æ¯ã¹å°ãªãããšããããã¯è«žå€åœã§äœ¿
çšã§ãããšã¯èšããå¯åå¿ïŒå¯äœçšïŒã®çºç
çšãããŠããæ°ããã¯ã¯ãã³ã®å°å ¥ã«æéãã
ãäžå¯é¿ã§ããããšã«å¯Ÿããåœæ°ã®ç解ãã
ããããšãªã©ãäºé²æ¥çš®æœçã®é ãããã¯ã¯
å¿ ãããååã«æµžéããŠããªãçŸç¶ããããŸ
ãã³ã»ã®ã£ããããšåŒã°ãããããŠãã®è§£æ¶ã
ãã
æ±ããããŠããŸããã ãããã®ããšãå«ããçã«ã¯ã¯ãã³ã»ã®ã£ãã 㯠ã¯ã㳠㧠é²ãããš ã 㧠ãã ç æ°ïŒVPDïŒ
ã解æ¶ããäºé²æ¥çš®ãæšé²ããŠããã«ã¯æ§ã ãª
Vaccine Preventable DiseasesïŒ ããã²ãš
ç«å Žã®è ããããããã®åéã§çå®ãªåãçµ
ãã§ãå€ãã®ã²ãšãæãããã«ãå°åéãçµæž
ã¿ãããŠããå¿ èŠããããŸãããäœããå€ãã®
çæ Œå·®ãªããåžæãããã¹ãŠã®ã²ãšãå ¬è²»ïŒå®
åœæ°ãäºé²æ¥çš®ã®éèŠæ§ãèªèããããšã倧
ææ¥çš®ïŒã§äºé²æ¥çš®ãåããããå¶åºŠã®å®çŸ
åã§ãããšèããŠããŸãã
ãå¿ èŠã§ããããšããããããŸã§ãæ¥æ¬å»åž« äŒã¯ããŸããŸãªåãçµã¿ãè¡ãããã®ææãšã
äºé²æ¥çš®ãå·¡ãç¶æ³ãå€åããŠããŠãããªã
ãŠãå¹³æïŒïŒå¹ŽïŒæããäºé²æ¥çš®æ³ã®äžéšã
ã§ãæ¬ååãåè¡ãããŸãããšã¯èª ã«æå®ã
æ¹æ£ãããïœïœææçãå°å ã®èºççèæ
åŸããã®ãšèããŸãã
æçãããããããŒããŠã€ã«ã¹ææçãå®æ æ¥çš®ãžè¿œå ãããŸãããããã«æ¬å¹ŽïŒïŒæãã
æ¬ååãå€ãã®æ¹ã ã«æŽ»çšãããçã®ã¯ã¯ãã³ã»
ã¯æ°Žçãæ人çšèºççèãå®ææ¥çš®ãšãªãã
ã®ã£ãã解æ¶ã®äžå©ãšãªãããšãåã«é¡ããã®
ãšãäºå®ãããŠããŸãã
ã§ãã
çŸåšãäºé²æ¥çš®æ³ã«åºã¥ãé¡çŸç ãšããŠãž ãããªã¢ãçŸæ¥ãããæ¥æ§ç°çœé«ç ( ããªãª )ã 麻ããã»é¢šãããæ¥æ¬è³çãç Žå·é¢šãçµæ žã ïœïœææçãå°å ã®èºççèææçãããã ãããŒããŠã€ã«ã¹ææçãããŸãé¡çŸç ãšã ãŠã€ã³ãã«ãšã³ã¶ãå®ææ¥çš®ãšããŠè¡ãããŠã ãŸãã ãã®ããã«è¿å¹Žãå®ææ¥çš®ãšããŠæ¥çš®ã§ãã㯠ã¯ãã³ãå¢å ããŠãããã®ã®ãæªã æµè¡æ§è³ äžè ºçïŒãããµãããïŒãåèçããã¿ãªã© ã®ã¯ã¯ãã³ã¯ä»»ææ¥çš®ã®ãŸãŸã®ç¶æ ã«ãã㟠ãããŸããå®ææ¥çš®ã®ã¯ã¯ãã³å¢å ã«ããäº é²æ¥çš®ã¹ã±ãžã¥ãŒã«ã®éå¯ã課é¡ãšãªã£ãŠã ãã被æ¥çš®è ã®è² æ ã軜æžããããã«ãæ··å ã¯ã¯ãã³ã®å°å ¥ãæãŸããŸãã
4 T H E VA LU E O F VACC I N ES
æ¥æ¬å»åž«äŒ äŒé· 暪å 矩æŠ
â
çã«ã¯ã¯ãã³ã»ã®ã£ããã解æ¶ãã äºé²æ¥çš®ãæšé²ããŠããã«ã¯ æ§ã ãªç«å Žã®è ããããããã®åé㧠çå®ãªåãçµã¿ãããŠããå¿ èŠããããŸããã äœããå€ãã®åœæ°ã äºé²æ¥çš®ã®éèŠæ§ãèªèããããšã 倧åã§ãããšèããŠããŸãã
â
T H E VA LU E O F VACC I N ES 5
THE
VA L U E OF
VA C C I N E S æ¥
æ¬ã¯ã¯ã¯ãã³åŸé²åœââããè³ã«ãããšèª°ããé©
äŒé²ç«ãšäºé²å»çãããããå»ççµæžçã瀟äŒçãªäŸ¿çã«
ãããã®ã§ã¯ãªãã§ãããããããããæ®å¿µãªã
ã€ããŠè§£èª¬ããŠããŸããç¶ãåœå ã®å®æ ã§ã¯ãæ¥æ¬ã®ã¯ã¯ãã³
ãå é²ååœã§å ¬è²»è² æ ã«ããå®ææ¥çš®åãããŠã
æ¿çã®å€é·ãš 2013 幎 4 æã®äºé²æ¥çš®æ³ã®æ¹æ£ã«é¢ããŠæŠ
ãæ°ŽãŒããããã ã³ãã¹ïŒãããµã颚éªïŒãšãã£ãããŒã·ã
説ããåçç§åŠå¯©è°äŒäºé²æ¥çš®ã»ã¯ã¯ãã³åç§äŒäŒé·ã®å²¡
ã¯ã»ã¯ã¯ãã³ãæ¥æ¬ã§ã¯åäººè² æ ã«ããä»»ææ¥çš®ã«ãšã©ãŸã£
éšä¿¡åœŠå çã«ç·æ¬ããŠããã ããŸããããŸããäžéšã§ãã
ãŠããã»ãã被æ¥çš®è ã®è² æ ã軜æžããå®å šæ§ãé«ããæ
åã ã®ã¯ã¯ãã³æ¥çš®ã®å®æ ãå·»æ«ã«èšèŒããŠããŸãã
æ°ã®ã¯ã¯ãã³ã®éçºã»å°å ¥ã®é ããªã©ãæ§ã ãªé¢ã§æ¥æ¬ãš äžçãšã®ãã¯ã¯ãã³ã»ã®ã£ããããèªèãããŠããŸãããªãã
å°åã»é«éœ¢å瀟äŒã«ã€ãé²ãæ¥æ¬ã¯ä»ãäžæ¬¡äºé²ãæšé²
ã®ã£ãããçããã®ã§ãããããã²ãšã€ã«ã¯ãäžçã«èªãå ¬
ããããšã§åœæ°ç·å»çè²»ãé©æ£åããåœæ°ã²ãšãäžäººãå¥
è¡è¡çãšé·å¯¿ç€ŸäŒãç¯ãäžããŠããéçšã§ãã¯ã¯ãã³ã®å¹
康ã§èªç«ããæ¥åžžç掻ãéãå¥åº·å¯¿åœãå šãããããã®å»
çšã瀟äŒçãªäŸ¡å€ã«å¯ŸããèªèãèããŠããããšãããã
çæ¿çã暡玢ããŠããŸããã¯ã¯ãã³æ¿çããã®äžç°ã§ããã
ããŸãã
ä»åŸãŸããŸããã®éèŠæ§ã¯å¢ããŠè¡ããã®ãšæãããŸãã㯠ã¯ãã³ã®äŸ¡å€ãšæ¥æ¬ã®ã¯ã¯ãã³æ¿çã®çŸç¶ããç解ããã
æ¬ååã§ã¯ãŸãã°ããŒãã«ãªèŠç¹ã§å ¬è¡è¡çäžã®ã¯ã¯ãã³
ãããããŠæ¬¡äžä»£ã®å®å¿ãå®ãããã«ãæ¬ååãã圹ç«ãŠ
ã®äŸ¡å€ãšååšæ矩ããããããŠèŠçŽããã¯ã¯ãã³ã«ãã瀟
ããã ããã°å¹žãã§ãã
6 T H E VA LU E O F VACC I N ES
T H E VA LU E O F VACC I N ES 7
ã¯ããã«
ⶠã¯ã¯ãã³ã®å ¬è¡è¡çå šè¬ã®äŸ¿çãšè²»çšé¢ã§ã®äŸ¿ç ã¯ã¯ãã³æ¥çš®ã®ã°ããŒãã«ãªåœ±é¿ïŒã¯ã¯ãã³æ¥
ãã 2010 幎ã®çŽ 58,000 人ãžãšæžå°ããã
å ããçŸæ£ãªã©ããã®ä»ã®ææçã«ããå䜵
çš®ã¯ãã°ããŒãã«ãã«ã¹ïŒåœéä¿å¥ãGlobal
ãã«ãã¯ã¯ãã³æ¥çš®ã倧ããªåœ¹å²ãæãããŠã
çãæ»äº¡ã®ãªã¹ã¯ã¯ãé«éœ¢è ã§ç¹ã«é«ããªã£ãŠ
HealthïŒã«å€å€§ãªåœ± é¿ãäžããæ æ çã®æ²
ãŸã 4ãããã«ã1980 幎代ã«å¹Žé 35 äžäººãš
ããŸãããã®ãããã¯ã¯ãã³ã®äžã«ã¯ç¹å®ã®å¹Ž
æ» ãææ çã«é¢é£ããæ»äº¡è æ°ãé害è æ°
æšå®ãããŠããããªãªçäŸã¯ã2012 幎ã«ã¯ã
霢局ã察象ãšãããã®ããããŸãããŸããç涯
ãæžå°ãããŠããŸããã å® å šãªé£²æ氎㮠確
ãã 223 äŸã«ãŸã§æ¿æžããŸãã 5ã
ã«ãããç¹å®ã®ééã§æ¥çš®ããããšã§ããã¹ãŠ
ä¿ ä»¥ å€ã§ã æ»äº¡çã®æžå°ã«å¯Ÿãã ããã»ã© 倧ããªåœ±é¿ãäžããŠããä»å ¥ã¯ä»ã«ã¯ãããŸ
ã®äººã ã«ç¶ç¶çãªå ç«ãããããã¯ã¯ãã³ãã ã¯ã¯ãã³ã¯ãããã幎霢局ã®äººã ã«è²¢ç®ããïŒ
ããŸããæ è¡è ã察象ãšããã¯ã¯ãã³ããç¹å®
ãã ã1980 幎ãã¯ã¯ãã³æ¥çš®ã«ãã£ãŠå€©ç¶
çŸåšãã¯ã¯ãã³ã«ãã£ãŠäºé²ãããææçã¯
ã®çŸæ£ã®ææãªã¹ã¯ã®é«ãå°ççå°åã«éå®
çãæ²æ» ãããŸãã 2ã1980 幎代ã«ãªã£ãŠã¯
35 ãè¶ ãããã®å€ããçåœã«é¢ããçŸæ£ãå
ããã¯ã¯ãã³ããããŸããçŸåšãç±³åœãªã©ã®åœã
ã¯ãã³æ¥çš®ãæ®åãããŸã§ã¯ã麻ç¹ã§æ»äº¡ãã
埩ãèŠèŸŒããªãæ©èœé害ãããããçŸæ£ã§ãã
ã§ã¯æ倧 17 ã®çŸæ£ãå®æäºé²æ¥çš®ã¹ã±ãžã¥ãŒ
人ã幎é 260 äžäººãäžåã£ãŠããŸãã 3ããã
ã€ã³ãã«ãšã³ã¶è b åïŒHibïŒããã¿ãŠã€ã«ã¹
ã«ã®å¯Ÿè±¡ãšããŠããŸã 6ãå³ 1 ã¯ãé幎ãæ人
ããã¯ã¯ãã³æ¥çš®ãå¹ åºãè¡ãããããã«ãªã£
ã«ãã£ãŠåŒãèµ·ããããçŸæ£ãªã©ãäžéšã®ææ
åãã®å®æäºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ãæ ¢æ§çŸæ£
ãçµæã2011 幎ã®æ»äº¡è æ°ã¯å¹Žé 158,000
çã¯å°å æã«æãé »ç¹ã«çºçããŸãã
æ£è ãæ è¡è ãªã©ã®é«ãªã¹ã¯è ã®äºé²æ¥çš®ã¹
1
人ã«ãŸã§æžå°ããŸãããåæ§ã«ãç Žå·é¢šã§æ» 亡 ãã æ° ç å æ° ãã1988 幎 ã® çŽ 80 äžäºº
ã±ãžã¥ãŒã«çã§å¯Ÿè±¡ãšãªã£ãŠããçŸæ£ã瀺ã㊠äžæ¹ãèºççèãã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ã«èµ·
ããŸãã
å°å
é幎
æ人
é«éœ¢è
æ ¢æ§çŸæ£æ£è
æ è¡è ã»å°å
ãžãããªã¢
ãžãããªã¢
ãžãããªã¢
ãžãããªã¢
èºççèçµåå
é»ç±
ç Žå·é¢š
ç Žå·é¢š
ç Žå·é¢š
ç Žå·é¢š
èºççèå€ç³äœ
ã³ã¬ã©
çŸæ¥å³
çŸæ¥å³
çŸæ¥å³
èºççèå€ç³äœ
A åèç
è žããã¹
èºççèçµåå
é«èçè
麻ç¹
æ°Žç垯ç¶ç±ç¹
B åèç
çç¬ç
æµè¡æ§è³äžè ºç
ã€ã³ãã«ãšã³ã¶
麻ç¹
æ¥æ¬è³ç
颚ç¹
æµè¡æ§è³äžè ºç
A åèç
ã€ã³ãã«ãšã³ã¶
颚ç¹
B åèç
ã€ã³ãã«ãšã³ã¶è b åïŒHibïŒ ããããããŒããŠã€ã«ã¹ 麻ç¹
ã€ã³ãã«ãšã³ã¶
æµè¡æ§è³äžè ºç 颚ç¹
é«èçè
ããªãª
ã€ã³ãã«ãšã³ã¶
B åèç A åèç æ°Žç ãã¿ãŠã€ã«ã¹ ã€ã³ãã«ãšã³ã¶ å³ 1. ãã¹ãŠã®å¹Žéœ¢å±€ã®å®æäºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ã§å¯Ÿè±¡ãšãªã£ãŠãããã¯ã¯ãã³ã§äºé²å¯èœãªçŸæ£ 7
1) Plotkin SL and Plotkin SA. A short History of vaccination. In Vaccines 5th edition, S Plotkin, W Orenstein and P Offit, Eds, Saunders Elsevier, China, 2008. 2) World Health Organization. The smallpox eradication program (SEP). May 2010. Available at: http://www.who.int/features/2010/smallpox/en/ 3) World Health Organization. Media Center. Measles Fact sheet no 286. Feb 2013. Available at: http://www.who.int/mediacentre/factsheets/fs286/en/index.html 4) World Health Organization. Immunization surveillance, assessment and monitoring. Maternal and neonatal tetanus (MNT) elimination. Available at: http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index.html. 5) Global polio eradication initiative. Polio this week. Available at: http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx 6) Centers for Disease Control and Prevention. Ten Great Public Health Achievements --- United States, 2001â2010. MMWR 2011; 60(19);619-623. 7) Centers for Disease Control and Prevention. Immunization schedules. http://www.cdc.gov/vaccines/schedules/
8 T H E VA LU E O F VACC I N ES
ã¯ããã«
éšåçæ¥çš®éå£ã«ãããŠææç㯠ã¯ã¯ãã³æªæ¥çš®è ã«äŒæããªã ã¯ã¯ãã³ã®éå£äºé²å¹æïŒå¹æçãªã¯ã¯ãã³ ã®æ¥çš®çãååã«é«ãå Žåãææçã®äŒæã é»æ¢ã§ããå¯èœæ§ããããŸãããã®å Žåãã¯ã¯ ãã³æ¥çš®ãåããªãã£ã人ãã¯ã¯ãã³æ¥çš®ãå ã¯ã¯ãã³æ¥çš®è
ããŠãå ç«ãç²åŸã§ããªãã£ã人ããææç
ææçäŒæãªã
ããä¿è·ãããããã«ãªããŸãããã®å¹æãé å£å ç«ãšãããŸãïŒå³ 2 åç §ïŒã倩ç¶çã¯ãã¯
ææçäŒææº
ã¯ãã³æªæ¥çš®è ãžã®ææçã®äŒæãé²ãã®ã« ååãªäººã ã«ã¯ã¯ãã³æ¥çš®ãè¡ã£ãããšã«ãã£
ã¯ã¯ãã³æªæ¥çš®è
ãŠæ ¹çµ¶ãããŸããã ææçã®äžã«ã¯ãä»ã®ææçãšæ¯èŒããŠå®¹æ
å³ 2. ã¯ã¯ãã³æªæ¥çš®è ãå«ããææçã®åºãããé²ãã¯ã¯ãã³ã®éå£å ç«å¹æ
ã«äŒæãããã®ããããŸããäŒæã容æãªæ æçã§ããã°ããã»ã©ããã®äŒæãé»æ¢ãã
ã¯ã¯ãã³ æ¥ çš® ã¯ã è²» çš å¯Ÿ å¹ æ ã® é« ã ä¿ å¥
å¹æã極ããŠé«ããGDP ã® 3 åæªæºã®å Žåã
ããã«å¿ èŠã«ãªãã¯ã¯ãã³ã®æ¥çš®çã¯é«ããªã
ä»å ¥ïŒã¯ã¯ãã³æ¥ çš®ã®è²» çšå¯Ÿå¹ æã¯ã ä¿ å¥
è²»çšå¯Ÿå¹æãé«ããšèããããŠããŸã 9ãç±³åœ
ãŸãã麻ç¹ã®ããã«æ¥µããŠäŒæããããææ
å éã®æ¯åºãå«ãããã® ä»ã®æ¯åºãšæ¯ èŒã
ã®å Žåã49,965 ç±³ãã«ä»¥äžã§è²»çšå¹æã極
çã®å Žåããã®äŒæãé»æ¢ããããã«ã¯ã極
ãŠã䞊ã¯ãããŠé«ããã®ãšãªã£ãŠããŸãïŒå³ 3
ããŠé«ã 10ã149,895 ç±³ãã«æªæºã§è²»çšå¯Ÿå¹
ããŠé«ãã¯ã¯ãã³ã®æ¥çš®çãå¹æãå¿ èŠãšãªã
åç §ïŒ8 ãäžè¬ã«ä»å ¥ã¯ããã®æ¯åºãäžäººåœã
æãé«ããšã¿ãªãããŸãã
ãŸãã
ãã®åœå ç·çç£ïŒGDPïŒä»¥äžã®å Žåãè²»çšå¯Ÿ
ãŸããéå£ã¯ã¯ãã³æ¥çš®ã¯ãå ç«æ©èœãäœäž ããŠãã人ãä¿è·ããŸããå ç«æ©èœãäœäžããŠ
ã¹ã¯ãªãŒãã³ã°æ€æ»ãšæ¯èŒããã¯ã¯ãã³æ¥çš®è²»çšïŒè³ªèª¿æŽçå幎
ãã人ã¯ãç¹ã«ææçã«çœ¹æ£ãããããªã£ãŠã ããäžã«ã¯ã¯ã¯ãã³æ¥çš®ãããŠãååã«å ç«ã
$1,000,000
ç²åŸã§ããªã人ãããŸããå€ãã®äººã«ã¯ã¯ãã³ ãã®ãããªäººãã¡ãææçã«çœ¹æ£ããããšãäº é²ã§ããå¯èœæ§ãããã®ã§ãã
$100,000 $10,000 ç±³ãã« /QALY ïŒå¯Ÿæ°ç®çïŒ
ãæ¥çš®ããããšã§åŸãããéå£å ç«ã«ãã£ãŠã
$1,000 $100 $10 $1 ã¯ã¯ãã³æ¥çš®
å¿è¡ç®¡ç³»çŸæ£
骚ç²é¬ç *
ãã
å³ 3. ä¿å¥åéã«ããããã®ä»ã®ä»å ¥ãšæ¯èŒããã¯ã¯ãã³æ¥çš®ã®è²»çšå¯Ÿå¹æ
ç®è¡ * ã¹ã¯ãªãŒãã³ã°ãšæ²»ç
8) Zhou F, Santoli J, Messonnier ML et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med 159: 1136-1144, 2005 9) World Health Organization. Choosing interventions that are cost effective (WHO-CHOICE). Cost-effectiveness thresholds. http://www.who.int/choice/costs/CER_thresholds/en/index.html 10) World Bank. GNI per capita, the Atlas method. Accessed Aug 19, 2013. Available at: http://data.worldbank.org/indicator/NY.GNP.PCAP.CD
T H E VA LU E O F VACC I N ES 9
ã¯ããã«
ã¯ã¯ãã³æ¥çš®ã«ãã£ãŠãç¹ã«ä¹³å¹Œå ãé«éœ¢è ã« ãããŠã¯ãæ²»çã«å¿ èŠãšãªãå€é¡ã®æ¯åºãå
è²»çšäŸ¿çæ¯
é¿ããããšãå¯èœã«ãªããŸããå®éãæ²»çè²» ããããçŸæ£ã®çºçãã¯ã¯ãã³ã«ãã£ãŠäºãé²
èºççèçµåå
ãããšãã§ãããããä¿å¥åéã®ãã®ä»å€ãã® ä»å ¥ãšç°ãªããã¯ã¯ãã³æ¥çš®ã¯å€ãã®å Žåãå»
A åèç
çè²»ã®ç·äœçãªåæžã«ã€ãªãããŸããæ°çš®ã®
ã€ã³ãã«ãšã³ã¶è b å
å°å äºé²æ¥çš®ã¯è²»çšåæžå¹æããããæ¥çš®ã« ãã£ãŠãããããã䟿çã®äŸ¡å€ã¯ãæ倧ã§è²»
äžæŽ»æ§ããªãª
çšã® 27 åã«ãªããŸãïŒå³ 4 åç §ïŒ11ã
æ°Žç
ç±³åœã§ã¯ãå°å æã®ã¯ã¯ãã³æ¥çš®ã«ãããå°
B åèç
å çŽ 400 äžäººåœããã®åºçã³ããŒãã«ãããŠ çŽ 42,000 ã®æ»äº¡ãš 2,000 äžäŸã®çœ¹ æ£ãäº
麻ç¹ãæµè¡æ§è³äžè ºçã颚ç¹
é²ãããŠããŸã 12ããã®çµæãåã³ããŒãã«ã ããŠãçŽæ¥è²»ïŒçŸæ£ã®æ²»çã«ãããè²»çšïŒã§
ãžãããªã¢ãç Žå·é¢šãçŸæ¥å³
140 åç±³ãã«ãéæ¥è²»ïŒçç£æ§ã®æ倱ãéžå€±
0
10
è³éããã®ä»ã«ãããè²»çšïŒã§ 690 åç±³ãã«
20
30 æ¯åºïŒãã«åœããã®äŸ¿çïŒç±³ãã«ïŒ
ã®è²»çšåæžãéæãããŸãïŒå³ 5 åç §ïŒã
å³ 4. ç±³åœã«ããã 8 å°å ã¯ã¯ãã³ã®è²»çšäŸ¿çæ¯ïŒå šã¯ã¯ãã³ã§äŸ¿çãè²»çšãäžåã
90 80 70
ïŒïŒåç±³ãã«
60 50 40
è²»çš åé¿è²»çš
30 20 10 0 -10 -20 çŽæ¥è²»
éæ¥è²»
å³ 5. ç±³åœã®å°å çŽ 400 äžäººåœããã®åºçã³ããŒãã«ãããå°å æã¯ã¯ãã³æ¥çš®ã«ããã£ã è²»çšãšã¯ã¯ãã³æ¥çš®ã§åæžã§ããè²»çš
11) 12)
Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services. Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability. National Academies Press, Washington DC, 2004. Zhou F. Updated economic evaluation of the routine childhood immunization schedule in the United States. Presented at the 45th National Immunization Conference. Washington, DC; March 28--31, 2011.
10 T H E VA LU E O F VACC I N ES
ã¯ããã«
ä¿ å¥åéã«äžããçŽæ¥çãªåœ± é¿ã®ä»ã«ãå¥ çµ æž æé·
康ã¯çµæžæé·ã«äžå¯æ¬ ã§ããããšãããã¯ã¯ ãã³æ¥çš®ã¯çµæžã«ãéèŠãªéæ¥ç圱é¿ãå㌠ããŸã 13ïŒå³ 6 åç §ïŒãGAVI ã¢ã©ã€ã¢ã³ã¹ã æ¯æŽããããã°ã©ã çãäœæåŸåœã®äºé²æ¥çš®
å¥
ããã°ã©ã ã«ãã£ãŠãã¯ã¯ãã³æ¥çš®ãåããå äŸã¯ããã®éçšæã«æåŸãå¢å ãããšã®æšå®
康
ç
ããããŸããèšãæããã°ãã¯ã¯ãã³æ¥çš®ã¯äž
ãæ
å¢é²
æ¬
ã«
è²ã ç ç£ æ§ã
ãã
éžå€±è³é
貯è
ã®
äœ
å
äž
æž
åœã®åœæ°ç·æåŸïŒGNIïŒã«åœ±é¿ãäžããããšã å¯èœãªã®ã§ãã
æ²»çã«ãããè²»çšã® äœæž
â· ã¯ã¯ãã³æ¥çš®ã¯ãã®ä»ã® äºé²å»çãžã®ã¢ã¯ã»ã¹ã æäŸãã äºå®ãããã¯ã¯ãã³æ¥çš®ã®éã«æäŸãããã ã®ä»ã®ä¿å¥ãµãŒãã¹ïŒã¯ã¯ãã³ã¯ç涯ã«ãã㣠ãŠæ±ºããããé éã§æ¥ çš®ãããããã ã¯ã¯ ãã³æ¥çš®ã®ããã®å蚺ã¯ããã®ä»ã®ä¿å¥ãµãŒ
å³ 6. ã¯ã¯ãã³æ¥çš®ã®åºç¯å²ã«ãããçµæžç圱é¿
ãã¹ãæäŸãã絶奜ã®æ©äŒãšãªããŸããäŸã ã°ããã®ä»ã®æ¯ å ä¿ å¥ä»å ¥ãäºé² æ¥çš®ã¹ã± ãžã¥ãŒã«ã«åãããŠæäŸããããšãå¯èœã«ãªã ãŸããäžçèŠæš¡ã§ã¿ãå Žåãæ¯åä¿å¥ä»å ¥ã« ã¯ãæä¹³ä»å ¥ããã©ãªã¢ã®äºé²ç®¡çããã¿ãã³ A è£çµŠãæ é€äžè¯ã®ç®¡çãèºçã®ç®¡çãäžç¢ ã®ç®¡çãHIV ã«æé²ãããåäŸã®ã±ã¢ãªã©ã å«ãŸããŠããŸã 14ãäŸãã°ãæ é€ã«ãŠã³ã»ãªã³ ã°ã家æèšç»ã貧è¡å¯Ÿçã®çµå£éå€ã®é 絊ã
ã¯ã¯ãã³æ¥çš®
ãã¿ãã³è£çµŠ
家æèšç»
ç£åŸã±ã¢ããã¯ã¯ãã³æ¥çš®ã«çµã¿åãããããš ãå¯èœã§ãïŒå³ 7 åç §ïŒã ã¯ã¯ãã³æ¥çš®æã«ãã®ä»ã®ä¿å¥ãµãŒãã¹ãçµ± åããããšã§ãè²»çšã®åæžãã¯ã¯ãã³æ¥çš®çã®
æä¹³ã»ç£åŸã±ã¢
æ é€äžè¯ãèºçã äžç¢ã®ç®¡ç
åäžããã®ä»ãµãŒãã¹ãžã®ã¢ã¯ã»ã¹æ¡å€§ããµãŒ ãã¹ãåããããã«å¿ èŠãªç§»åãæéé¢ã§ã® 家æã®è² æ 軜æžã®å¯èœæ§ããããŸãã
å³ 7. ã¯ã¯ãã³æ¥çš®æã«çµ±åå¯èœãªãã®ä»ã®ä¿å¥ãµãŒãã¹
13) World Health Organization. The partnership for maternal, newborn, and child health. PMNCH Knowledge Summary #25 Integrating immunization and other services for women and children. 2013. Available at: http://www.who.int/pmnch/topics/knowledge_summaries/knowledge_summaries_25_integrating_immunization/en/index.html 14) Bloom DE, Canning D, Weston M. The value of vaccination. World Economics 2005; 6(3): 1 - 39. Available at: www.who.int/immunization_supply/financing/value_vaccination_bloom_canning_weston.pdf
T H E VA LU E O F VACC I N ES 11
ã¯ããã«
âž ã¯ã¯ãã³æ¥çš®ã®å®å šæ§ãš ãªã¹ã¯ ã¯ã¯ãã³ã®å®å šæ§ïŒã¯ã¯ãã³ãèªçºããå ç« åå¿ã®ãããã¯ã¯ãã³æ¥çš®ã§å€å°ã®äžå¿«æã çããå ŽåããããŸããããããã¯ã¯ãã³ã«é¢ é£ããæ害äºè±¡ã®å€§åã¯ãäžè¬çã«æ³šå°éšäœ ã®çã¿ã軜床ã®çºç±ãªã©ã軜埮ã§äžéæ§ã®ã ã®ã§ããïŒè¡š 1 åç §ïŒããããããé節ãªæ害 äºè±¡ãçºçŸããããšã¯çšã§ããäžéšã®é節㪠æ害äºè±¡ã«ã¯ãæ°çŸäžåã®ã¯ã¯ãã³æ¥çš®ã§ 1 äŸããçºçŸããªããããªæ¥µããŠçšãªãã®ããã ãŸã 15ããŸããããŸãã«ãçºçŸçãäœãããã
ã¯ã¯ãã³
çã¿ã è «ããçºèµ€
BCGïŒçµæ žäºé²ïŒ
90 ïœ 95%
ã€ã³ãã«ãšã³ã¶è b å B åèç
å°å 5%
麻ç¹ïŒéº»ç¹ãæµè¡æ§è³äž è ºçã颚ç¹ïŒéº»ç¹ãé¢šç¹ çµå£ããªãª
ãã®ãªã¹ã¯ãæ£ç¢ºã«è©äŸ¡ã§ããªããããªé節ãª
ç Žå·é¢šïŒç Žå·é¢šã
æ害äºè±¡ããããŸã 16ãåµãæçç©è³ªããŒã©
ãžãããªã¢
ãã³ãªã©ãäžéšã®ã¯ã¯ãã³ã«å«ãŸããæåã埮 éå çŽ ã«ææãªäººãããŸãããããããå Žå
5 ïœ 15% æ人 15%
38âã è¶ ããçºç±
å šèº«çç¶
2 ïœ 10% 1 ïœ 6%
ïœ 10%
5 ïœ 15%
çºç¹ 5%
極ããŠçš
< 1%
äžç¢ãé çãçèç < 1%
ïœ 10%
éæçããã³åŠæ æ ïœ 25%
ïœ 10% è¿œå æ¥çš® 50 ïœ 85%
è¡š 1. å é²åœã®å®æäºé²æ¥çš®ã§äœ¿çšãããŠããã¯ã¯ãã³ã«å€ãæ害äºè±¡
ãé€ããéåžžã¯ãçšãŸãã¯æ¥µããŠçšãªæå®³äº è±¡ã®åå ã¯æããã«ãªã£ãŠããŸãããçšãã㳠極ããŠçšãªæ害äºè±¡ã¯ãå ç«å¿çã®å人差㫠é¢é£ããŠãããšèããããŠããŸãã ã¯ã¯ãã³ã®ãªã¹ã¯ã«é¢ããæ å ±ã®æäŸïŒäºé²æ¥ çš®ã®äŸ¿çãšãªã¹ã¯ã«é¢ããæ å ±ãžã®äžè¬åžæ° ã®èŠæ±ã¯ããŸããŸãé«ãŸã£ãŠããŸãããã®ããã
èšæ©å¿å€ãªå¯Ÿå¿
å»çæäŸè ãã¯ã¯ãã³ã«é¢ããæ¿ç決å®è ã¯ã åã ã®å°åã§åŸãããææ°æ å ±ããæ£è ãä¿ è·è ã«æäŸããå¿ èŠããããŸãïŒå³ 8 åç §ïŒã ç±³åœã§ã¯ãçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã éããŠãäºé²æ¥çš®ã®ãªã¹ã¯ãšäŸ¿çã«é¢ããæ å ± ãææžã§äžè¬åžæ°ã«æäŸããŠãããã¯ã¯ãã³
ç®æšã¯ã被æ¥çš®è ãæ å ±ã«åºã¥ããŠæ¥çš®ã« é¢ããææ決å®ãããããšã
æ¥çš®ã®éã«ã¯æ¯åãã¯ã¯ãã³æ å ±ã·ãŒãïŒVISïŒ ãæäŸããããšã矩åä»ããããŠããŸããåœ å®¶çãªäºé²æ¥çš®ã¬ã€ãã®å€ããäžçä¿å¥æ©é¢ ã®ã¬ã€ãã©ã€ã³ã§ã¯ãäºé²æ¥çš®ã®ãªã¹ã¯ãšäŸ¿ç ã«ã€ããŠã©ã®ããã«äŒéãããã«ã€ããŠãå»ç
ãªã¹ã¯ãšäžç¢ºå®æ§ãå®éåããããš
æäŸè ã«å©èšãæäŸããŠããŸãããã®å©èšã« ã¯ãäºé²æ¥çš®åŸã®æ害äºè±¡ïŒAEFIïŒã«é¢ãã æ å ±æäŸã«ã€ããŠãå«ãŸããŠããŸãã
å³ 8. ã¯ã¯ãã³æ¥çš®ã®ãªã¹ã¯ã³ãã¥ãã±ãŒã·ã§ã³ã®äž»èŠæŠå¿µ
15) Australian government. The Australian immunization handbook 9th edition. 1.5. post-vaccination procedures. http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-adverse 16) Public Health Agency of Canada. Canadian Immunization Guide. Part 2 Vaccine safety and Adverse Events Following Immunization. http://www.phac-aspc.gc.ca/publicat/cig-gci/p02-01-eng.php
12 T H E VA LU E O F VACC I N ES
ã¯ããã«
ã¯ã¯ãã³ã«é¢é£ãããªã¹ã¯ã®è©äŸ¡ïŒã¯ã¯ãã³é¢ é£ã®ãªã¹ã¯ããŒã¿ã¯ããŸãåèšåºæ®µéã§çæ ããããã®åŸãå®å šãªå Žåã¯ã¯ã¯ãã³ã®èšåº éçºã§çæãããŸããæ¿åºã®èŠå¶åœå±ã¯ã㯠ã¯ãã³ã®éçºããã»ã¹äžã®å®å šæ§ããŒã¿ãã ã³æ¿èªç³è«æã®å®å šæ§ããŒã¿ã泚ææ·±ãç²Ÿæ» ããŸããå®å šæ§ããŒã¿ã¯ãéåžžãäœå人ã㮠被éšè ããåŸãããŸãããèŠå¶åœå±ããã¯ã¯ ãã³æ¿èªåŸã«åéãããè¿œå å®å šæ§ããŒã¿ã® æåºãæ±ããããå ŽåããããŸãã倧åã®åœã¯ èªçºçïŒãŸãã¯ååçïŒå®å šæ§ç£èŠã·ã¹ãã ãæ¡çšããŠããããã®å€ããè£è¶³çãªèœåç ç£èŠã·ã¹ãã ã䜿çšããŠããŸãããããã®ã㌠ã¿ã¯ãæéçãªå¶éãèšããããšãªããäžè¬ åžæ°ãæ£è ããã®ä¿è·è ãã¯ã¯ãã³ã¡ãŒã«ãŒã å»çæäŸè ããåéãããŠããŸããé節ãªæ 害äºè±¡ãå ±åãããå Žåããããäºè±¡ã®çæ çããã³é·æçãªè¿œè·¡èª¿æ»ãéå§ãããŸãã äºé²æ¥çš®ç»é²ãšå»çèšé²ãšããªã³ã¯ãããããš ã«ãã£ãŠãäºè±¡ã®çºçŸçãæšå®ããããšãå¯èœ ã«ãªããŸãã å®å šæ§ç£èŠã¯ãæ§ã ãªã¬ãã«ã§å®æœãããå Ž åããããŸãïŒå³ 9 åç §ïŒ
åœãè¶ ããèªçºçå®å šæ§ç£èŠ ïŒWHO ã®ã¯ã¯ãã³ã®å®å šæ§ã« é¢ããè«®åå§å¡äŒïŒ
ååœã®èªçºçå®å š
ååœã®èœåçå®å š
æ§ç£èŠïŒå»åž«ãå°åä¿å¥åœå±
æ§ç£èŠïŒå°éå»çã»ã³ã¿ãŒã
ããã³åœç«æœèšããïŒ
倧åŠããã³ç¬¬ IV çžèšåºè©ŠéšããïŒ
å³ 9. ã¯ã¯ãã³é¢é£ãªã¹ã¯ã®ãã«ãã¬ãã«è©äŸ¡
T H E VA LU E O F VACC I N ES 13
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
ⶠææçã«ãã瀟äŒçæ倱ãé²ã
ⷠ矩åèŠå®ãã åªå矩åèŠå®ãž
æŠåŸéããªãé ã®æ¥æ¬ã¯ææçãè延ããã
ãããã瀟äŒæ å¢ãããã1976 幎ã«äºé²æ¥çš®
1992 幎 12 æ 18 æ¥ã ãäºé²æ¥çš®è¢«å®³æ± 京é
ãã£ããããææçã®æµè¡ãããããŠç€ŸäŒç
æ³ãæ¹èšãããŸãããæ¹èšåŸã¯çœ°åèŠå®ãªã
å£èšŽèšãã®æ§èšŽå¯©å€æ±ºãæ±äº¬é«çè£å€æïŒå®
ãªäººçè³æºã®æ倱ãæããããšãæ¥åã§ããã
ã®çŸ©åæ¥çš®ïŒç·æ¥èšæãé€ãïŒãšãªãã察象
æžé埳è£å€é·ïŒã§èšãæž¡ãããŸãããå蚎èš
1948 幎ã瀟äŒå šäœãææçã®è åšããé²è¡
çŸæ£ããè žããã¹ãªã© 4 çŸæ£ãå€ãããäžæ¹
㯠1952 幎ãã 1974 幎ã«ãããŠçš®çãªã©ã®
ããæ段ãšããŠãäºé²æ¥çš®æ³ããå¶å®ãããŸãã
ã§ãæ°ãã«é¢šç¹ã麻ç¹ãæ¥æ¬è³çãè¿œå ãã
äºé²æ¥çš®ãåããåŸãæ»äº¡ããããå¯äœçšã«
çããïŒå€©ç¶çïŒãçŸæ¥å³ãè žããã¹ãªã©ã® 12
ãŸãããåæã«å¥åº·è¢«å®³ææžå¶åºŠãåµèšããã
ããå¿èº«é害ã®åŸéºçãæ®ã£ãæ£è ãšãã®äž¡
çŸç ã察象ãšãããæ¥çš®ãæ ã£ãå Žåã¯çœ°å
èªæ²»äœããã³åœã®ææžçŸ©åãææåãããŸã
芪ã 62 家æ 159 人ããåœãçžæåãæ害è³
ãç§ããããã矩åæ¥çš®ããšããŠå°å ¥ãããŸã
ãã
åãæ±ãããã®ã§ããå®æžè£å€é·ã¯ãæ¥çš®ãå
ããçµæãšã㊠60 幎代以éãææçã®çœ¹æ£ ïŒ
é¿ãã¹ãçŠå¿è ã«äºé²æ¥çš®ãå®æœãããªãã
æ°ãšæ»äº¡è æ°ã¯æžå°ããŠãããŸãïŒå³ïŒïŒ ãã
ãã®ååãªäœå¶ã¥ãããããŠããããã§ããã
ããããã®äžæ¹ã§ 60 幎代åŸåãçš®çåŸè³ç
ãæ ã£ãé倱ããã£ãããšããŠè¡æ¿è²¬ä»»ãèª
ãªã©ã®å¥åº·è¢«å®³ã瀟äŒåé¡åããŠãããŸããã
ããæå®³è³ åã®æ¯æããåœã«åœããŸãããã
ãŸããè žããã¹ãªã©ã§ã¯ã¯ãã³ä»¥å€ã®æå¹ãª
ã®åžæ³å€æã¯ãã®åŸã®ã¯ã¯ãã³æ¿çã«åœ±é¿ã
äºé²æ段ãå¯èœã«ãªããã¯ã¯ãã³æ¿çã¯äžå®
ãŠãããŸãïŒã
ã®èŠçŽããè¿«ãããŸããã 1994 幎ã®æ¹æ£äºé²æ¥çš®æ³ã§ã¯ãå®ææ¥çš®ã« ãããããã矩åæ¥çš®ãããåªå矩åããžãš å³ïŒ äºé²æ¥çš®ã®æŽå²ãšæ£è æ°ã®æšç§»
å€æŽãããã»ããã€ã³ãã«ãšã³ã¶ãªã©èšæã® äºé²æ¥çš®ã¯å»æ¢ãããŸãããäžè«ã«æŒããã 圢ã§ãéå£æ¥çš®ããšããåœã®èŠå¶ãç·©åããã å人ïŒä¿è·è ïŒãæ¥çš®ã®æ矩ãšãªã¹ã¯ãç解ã ãããã§æ¥çš®ã«åæãããåå¥æ¥çš®ããžãšå€§ã ã転æããã®ã§ãã ãªããæ¥æ¬ã®äºé²æ¥çš®ã«ã¯äžèšã®å®ææ¥çš®ã® ã»ããäºé²æ¥çš®æ³ã§èŠå®ãããŠããªãä»»ææ¥ çš®ã® 2 çš®é¡ããããŸããå®ææ¥çš®ã¯ååãšã ãŠèªå·±è² æ ã¯ãããŸãããäžãäžãå¥åº·è¢«å®³ ãçããå Žåã¯ãåçåŽå倧è£ãå æé¢ä¿ã èªå®ã次第ãèªæ²»äœã«ããææžçµŠä»ã®å¯Ÿè±¡ãš ãªããŸãïŒãäžæ¹ãä»»ææ¥çš®ã¯èªæ²»äœã®è£å©ã
æšæäžç倫ã»å¹³å±±å®å®ã»å ºæ¥çŸ ç·šèïŒäºé²æ¥çš®ã®æåŒã ïŒç¬¬ 11 çïŒ : è¿ä»£åºç , 2007. p.3 å³ïŒããäœæ
ãªãéããå人ãä¿è·è ãè²»çšãèªå·±è² æ ã ãå¿ èŠããããŸãããŸããå¥åº·è¢«å®³ã«ã€ããŠã¯ 1980 幎å¶å®ã®ç¬ç«è¡æ¿æ³äººå»è¬åå»çæ©åš ç·åæ©æ§æ³ã«åºã¥ãææžå¯Ÿè±¡ãšãªããŸããïŒã å®ææ¥çš®ãšã¯å 容ãç°ãªããŸãã
ïŒïŒ æšæäžç倫ã»å¹³å±±å®å®ã»å ºæ¥çŸ ç·šèïŒäºé²æ¥çš®ã®æåŒã ïŒç¬¬ 11 çïŒ : è¿ä»£åºç , 2007. p.3 å³ïŒããäœæ ïŒïŒ 西åç« ïŒäºé²æ¥çš®äºæ ãšåœå®¶è³ å責任ïŒæ³æ¿çè« 26(2),1-56,1993. ïŒïŒ åçåŽåçïŒäºé²æ¥çš®å¥åº·è¢«å®³ææžå¶åºŠ http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou20/kenkouhigai_kyusai/ ïŒïŒ ç¬ç«è¡æ¿æ³äººå»è¬åå»çæ©åšç·åæ©æ§æ³ http://law.e-gov.go.jp/htmldata/H14/H14HO192.html
14 T H E VA LU E O F VACC I N ES
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
âž ãåå¥ãæ¥çš®ã®å眪
å³ 2 æ人麻ç¹ã®å¹Žå¥ã»é±å¥çºçç¶æ³ïŒ1999 幎第 14 é±ã 2007 幎第 51 é±ïŒ
éå£æ¥çš®ããåå¥æ¥çš®ãžããããã¯çŸ©åèŠå® ããåªå矩åãžã®è»¢æã¯ãå人ã®ææ決å®ã å°éããäžæ¹ã§ã家åºã®çµæžç¶æ³ããå®ææ¥ çš®ã®ã¯ã¯ãã³ã§ããããšãç¥ããªãã£ãããªã© é©æ£ãªæ å ±ã®æ¬ åŠã«ããæ¥çš®çã®äœäžãæã ãŸããããã®çµæãäºé²æ¥çš®ã®æçµçãªç®æš ã§ãããéå£å ç«ãã®éæãšããç¹ã§åŸéã äœåãªããããŸããäºå®ã2007 幎ã«ã¯æ±æ¥æ¬ åšäœã®10 ã 20 代ååã®è¥è ãäžå¿ã«éº»ç¹ ïŒã¯
åœç«ææçç 究æïŒIDWR Vol.9 No.51,2007.
ããïŒãæµè¡ãïŒå³ïŒïŒïŒãåçåŽåçãç·æ¥ ã«å¯Ÿçãè¬ããŠããŸãããŸãã2013 幎ã«éŠéœ åãé¢è¥¿å°æ¹ãªã©ã®éœåžéšã§é¢šç¹ãæµè¡ã㟠ãããïŒïŒå³ïŒïŒïŒãæ£è ã¯éå»ã«å®æäºé²æ¥çš® ã®æ©äŒããªãã£ã 2013 幎æç¹ã§ 35 ã 51 æ³ ã®ç·æ§ãšäºé²æ¥çš®ã®å®æœçãäœãã£ã 26 ã 34 æ³ã®ç·å¥³ã«éäžããŠããŸããïŒå³ïŒïŒïŒã æ¥çš®çã®äœäžãåæµè¡ã«ç¹ãã£ãäŸã§ã¯ãçŸ
å³ïŒ 颚ãã环ç©å ±åæ°ã®æšç§» 2009-2013 幎ïŒç¬¬ïŒã 52 é±ïŒ â» ä»åŸã®è¿œå ãä¿®æ£ã«ãããå幎ã®çŽ¯ç©å ±åæ°ã¯å€ããå¯èœæ§ããããŸãã 16000
æ¥å³ ã æåã§ãã æŠ åŸã æ¥æ¬ã§ã¯çŸæ¥å³ ã æµè¡ãïŒäžäººä»¥äžã®æ»äº¡è ãèšé²ããŠããŸã ãããããã1949 幎ã«çŸæ¥å³ã®ã¯ã¯ãã³ãã 58 幎ã«ãžãããªã¢ãšã®æ··åã¯ã¯ãã³ïŒDPïŒã å°å ¥ããããšãæ£è æ°ã¯æ¿æžããŸããïŒå³ïŒïŒïŒã ããããã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡äºäŸã瀟äŒå é¡ãšãªãã1975 幎 2 æã«ã¯ã¯ãã³æ¥çš®ã¯äžæŠã äžæ¢ãããŸãã2 ãµæåŸã® 4 æã«åéãããã ã®ã®æ¥çš®çã¯é·ããå埩ããã1979 幎ã¯å¹Žé 1 äž 3000 人ã®æ£è ãš 20 人以äžã®æ»è ãåº ãäºæ ãçããŠããŸãã
14000 12000 2013 幎 n = 14,357 10000
2012 幎 n = 2,392 2011 幎 n = 378
8000
2010 幎 n = 87 2009 幎 n = 147
6000 4000 2000 ïŒ
1 3
5
7
9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 é±
åœç«ææçç 究æïŒé¢šç¹ çºçååèª¿æ» éå ±ããŒã¿ïŒ2013 幎第 52 é±ïŒ2014 幎 1 æ 7 æ¥çŸåšïŒ
ïŒ) åœç«ææçç 究æïŒIDWR Vol.9 No.51,2007. ïŒ) åœç«ææçç 究æïŒIASR Vol.34,No4(No.398)April 2013. ïŒ) åœç«ææçç 究æïŒé¢šç¹ çºçååèª¿æ» éå ±ããŒã¿ïŒ2013 幎第 52 é±ïŒ2014 幎 1 æ 7 æ¥çŸåšïŒ ïŒ) åœç«ææçç 究æïŒIASR Vol.18, No.5,1997.
T H E VA LU E O F VACC I N ES 15
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
å³ïŒ 幎霢å¥é¢šãã环ç©å ±åæ°å²åïŒç·å¥³å¥ïŒ2013 幎第ïŒã 52 é±ïŒn=14,357ïŒ
ç·æ§ n = 10,985
1212
4
24
34
23
9
0æ³ 1~4 æ³ 5~9 æ³ 10~14 æ³ 15~19 æ³ 20~29 æ³
å¥³æ§ n = 3,372
30~39 æ³ 1 4
3
3
11
40
16
9
13
40~49 æ³ 50 æ³ä»¥äž
0%
20%
40%
60%
80%
100%
åœç«ææçç 究æïŒé¢šç¹ çºçååèª¿æ» éå ±ããŒã¿ïŒ2013 幎第 52 é±ïŒ2014 幎 1 æ 7 æ¥çŸåšïŒ
å³ïŒ çŸæ¥å³å±åºæ£è æ°ããã³æ»è æ°ã®æšç§»ã ïŒ1947 ã 1995 å¹ŽïŒ ïŒåççäŒæç çµ±èšã»äººå£åæ çµ±èšïŒ 1,000,000
æ£è æ»è
100,000 ã¯ã¯ãã³æ¥çš®äžæ¢ (75.2 ã 4) æ£
粟補ã¯ã¯ãã³éå§
10,000
è æ° ã»
1,000
æ» è æ°
100
10
1 1945
50
55
60
65
70
75
åœç«ææçç 究æïŒIASR Vol.18, No.5,1997.
16 T H E VA LU E O F VACC I N ES
80
85
90
95 幎
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
⺠æ°èã»åèææçãš ã¯ã¯ãã³ã»ã®ã£ãã æèè¬ãã¯ã¯ãã³ã®éçºãè¡çç¶æ ãæ é€ç¶ æ ã®æ¹åãææããããäžèŠãææçã®è åš ã¯éå»ã®ãã®ã®ããã«æããŸããããããã® 20 幎ã®éã«ãããããŸã§ç¥ãããŠããªãã£ã ææçãåºçŸããæ°ããªç åäœã確èªããã ããã«ãªããŸããããŸããåŸå§ãããã«ã¿ã ãææçã§ããäžçã®ã©ããã§æœäŒããŠããã ãããã¯å€ç°ãèµ·ããããšã«ãã£ãŠåã³æµè¡ã® å ããèŠããããšããããŸãããã®ãããªçŸæ£ ããæ°èã»åèææçããšãããŸãããåœé çã«èŒžééãå¢ããããšã«ãããçºçãªã¹ã¯ã ãŸãäžçèŠæš¡ã®ãã®ãšãªã£ãŠããŸãã2009 幎 ã«æµè¡ãããæ°åã€ã³ãã«ãšã³ã¶ïŒA/H1N1ïŒã ãããäŸã§ãããã幞ããç åæ§ãäœããæ¥æ¬
â¹ é«éœ¢å瀟äŒãè¿ããŠ
ã§ã¯æ°Žé察çãæ©æã®æã€ã³ãã«ãšã³ã¶è¬æ äžãå¥å¹ããããšããã倧èŠæš¡ãªæµè¡ã«ã¯è³ã
21 äžçŽãç®åã«ãå»çæ¿çãšåæ§ã«ã¯ã¯ãã³
2001 幎ãããããç¶æ³ãèæ¯ã«äºé²æ¥çš®æ³ã
ãŸããã§ããããä»åŸãåãããã«å¯ŸåŠã§ãã
æ¿çã¯é«éœ¢å瀟äŒãžã®å¯Ÿå¿ãè¿«ãããããšã«
æ¹æ£ãããŸããããã«äŒŽã 65 æ³ä»¥äžã®é«éœ¢è
ãšã¯éããŸããã
ãªããŸããããšãã°ãå£ç¯æ§ã€ã³ãã«ãšã³ã¶
ãš 60 ã 64 æ³ã®å¿èãè èãåŒåžåšããã
ã¯ãè€æ°ã®åºç€çŸæ£ãããäœåãäœäžããŠã
å ç«äžå šãŠã€ã«ã¹ïŒHIVïŒã§å ç«ãäœäžããŠã
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã¯å¯åå¿ãå¥åº·è¢«å®³ãžã®
ã 65 æ³ä»¥äžã®é«éœ¢è ã«ææãããããäžæŠ
ãå Žåã¯ãå®ææ¥çš®ïŒäºé¡çŸç ïŒããšããŠãäº
察å¿ã«å€§ããå·Šå³ãããŠããŸããããã®çµæã
çºçãããšé«ç±ã«ããæ¶èãããç°¡åã«éç
é²æ¥çš®æ³ã®æ çµã¿ã§äžéšå ¬è²»è² æ ã«ããã€ã³
ã¯ã¯ãã³å°å ¥ãåŸæã«åããæ°èŠã¯ã¯ãã³ã
ã®èºçãå¿äžå šãããããããããšãç¥ãããŠ
ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®ãå¯èœã«ãªããŸããã
æ··åã¯ã¯ãã³ã®å°å ¥æ¿èªã®é ããæ¿èªããã
ããŸãã98/99 幎ã·ãŒãºã³ã¯ä»è·æœèšãé«éœ¢
ãŠãå®ææ¥çš®ãšãããªãããã«æ®åãé ãã
çãé«ãå ¥é¢ç æ£ã§ã®éå£ææãšæ»äº¡è ãçž
ã»ããã¯ã¯ãã³ã®æ¥çš®åæ°ãæé ãäžçæšæº
ïŒ
次ãã瀟äŒåé¡åããŸãã ãåœæã ãä»»ææ¥
ãšããé¢ããŠãããªã©æ§ã ãªåé¡ãæããã«
çš®ãã ã£ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã¯ãæ¥çš®ç
ãªããæ¥æ¬ãšå é²åœãšã®ãã¯ã¯ãã³ã»ã®ã£ããã
ã 1979 幎㮠67.9% ããçŽ 2 å²ã«ãŸã§äœäžã
ãšããŠèªèãããããã«ãªã£ãŠããŸãã
ãŠããŸããããé§ã蟌ã¿æ¥çš®ã§ã¯ã¯ãã³äžè¶³ã çãããŸã§ã«ãªããŸããïŒïŒã
ãã¯ã¯ãã³ã»ã®ã£ãããã®èæ¯ã«ã¯ãäºé²æ¥çš® å¶åºŠãæ€èšããåžžèšã®å°é家å§å¡äŒã®äžåšã ãããŸããããããã2009 幎ã®ãæ°åã€ã³ã ã«ãšã³ã¶ (A/H1N1)ãã®æµè¡ãããããããã 2009 幎ã«äºé²æ¥çš®éšäŒ ïŒéšäŒé·ïŒå è€é倫æ°ïŒ ãçºè¶³ãã2013 幎 4 æããã®æèšãåãã 圢ã§äºé²æ¥çš®æ³ãæ¹æ£ãããã«è³ããŸããã
ïŒ) åœç«ææçç 究æïŒIASR Vol.20, No.12, 1999. ïŒïŒ) åœç«ææçç 究æïŒIASR Vol.23, No.12, 2002.
T H E VA LU E O F VACC I N ES 17
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
â» æ¹æ£äºé²æ¥çš®æ³ãš äºé²æ¥çš®åºæ¬èšç»ã®çå® æ¹æ£äºé²æ¥çš®æ³ã§ã¯ãå®ææ¥çš®ãæµè¡ãæå¶ ããé¡çŸç ãšå人ã®äºé²ãéèŠãã B åé¡ ãšããåé¡çŸç 察象ã¯ã¯ãã³ãšããŠæ°ãã« Hib( ã€ã³ãã«ãšã³ã¶ b åè ) ã¯ã¯ãã³ãå°å çšèºççèã¯ã¯ãã³ãããããããŒããŠã€ã«ã¹
å³ïŒ å®ææ¥çš®ã®è²»çšè² æ ïŒ2013 幎床äºé²æ¥çš®æ³æ¹æ£ä»¥éïŒ
A é¡çŸç å®æœäž»äœ å®ææ¥çš® (A é¡çŸç ) ãžãããªã¢ã»çŸæ¥ããã» ããªãªã»ç Žå·é¢šã»éº»ãã㻠颚ããã»æ¥æ¬è³çã»BCGã» Hibã»å°å çšèºççèã» ããããããŒããŠã€ã«ã¹ ææçã»æ°Žç
åžçºæ åžçºæ 9 å²ãå°æ¹äº€ä»çšã§æåœ
ïŒHPVïŒã¯ã¯ãã³ãçµã¿å ¥ããããŸããïŒïŒããŸãã å®æœäž»äœ
亀ä»çšã§è² æ ãããšããŠããŸãïŒå³ïŒïŒïŒïŒã
æ¥çš®ã»ã¯ã¯ãã³åç§äŒïŒåç§äŒé·ïŒå²¡éšä¿¡åœŠæ°ïŒ ãçºè¶³ããç¶ç¶çãªè°è«ãè¡ãããããã«ãª
å®è²» ãªã©
B é¡çŸç
æ¥çš®è²»çšã A åé¡çŸç ã«ã€ããŠã¯ 9 å²ãå°æ¹
ããã«ã2013 幎 4 æã«ã¯åçç§åŠå¯©è°äŒäºé²
è² æ
å®ææ¥çš® (B é¡çŸç ) ã€ã³ãã«ãšã³ã¶ ( é«éœ¢ )ã» æ人çšèºççè
åžçºæ
ãã2014 幎ç§ããæ°Žçã¯ã¯ãã³ã A åé¡çŸ ç ã«ãé«éœ¢è ã察象ãšããæ人èºççèã¯ã¯
è² æ
( äœæåŸè å )
åžçºæ ( å®è²»ãªã© )
3 å²çšåºŠã å°æ¹äº€ä»çšã§æåœ
â» ã€ã³ãã«ãšã³ã¶ ( é«éœ¢ ) ã«ã€ããŠã å€ãã®åžçºæã§äžéšå®è²»ãæ€åããŠããã
åçåŽåçïŒäºé²æ¥çš®åºæ¬èšç»ã®çå®ã«ã€ããŠããæç²
ãã³ã B åé¡çŸç ã«å ããæ¹éãæããã«ã ãŠããŸãã 2013 幎床äžã«ã¯ãä»åŸã®äºé²æ¥çš®å¶åºŠã®æ¹
å³ïŒ äºé²æ¥çš®åºæ¬èšç»ã®çå®ã«ã€ããŠ
åæ§ã瀺ããäºé²æ¥çš®åºæ¬èšç»ããçå®ãã
çµç·¯
ãäºå®ã§ãïŒå³ïŒïŒïŒïŒããã察çåºæ¬æ³ã«åºã¥ ããã察çåºæ¬èšç»ãæ¥æ¬ã®ããå»çã®ãã ã©ãã°ã»ã©ã°ããšå°åéæ Œå·®ãæ¯æ£ããŠããã ãã«ãæ¥æ¬ã®ã¯ã¯ãã³æ¿çãæ°ãã段éãè¿ã ãŠããŸãã
å¹³æ 25 幎 3 æã®äºé²æ¥çš®æ³æ¹æ£ã«äŒŽããäºé²æ¥çš®åºæ¬èšç» ( äºé²æ¥çš®ã«é¢ããæœçã®ç·åçãã€èšç»ç ãªæšé²ãå³ãããã®èšç» ) ãçå®ããããšãšããã25 幎床äžã«å®ããããšãšããŠããã ãããŸã§ãåçç§åŠå¯©è°äŒäºé²æ¥çš®ã»ã¯ã¯ãã³åç§äŒçã§å¯©è°ãããåçåŽåçæ¡ããŸãšããããã * äºé²æ¥çš®ã»ã¯ã¯ãã³åç§äŒã«ãããŠãå°ãªããšã 5 幎ããšãç®éã«èŠçŽããæ€èšã
äºé²æ¥çš®åºæ¬èšç»ã®å 容 ( äºé²æ¥çš®æ³ç¬¬ïŒæ¡ã«ãããŠèŠå® ) 第 1 äºé²æ¥çš®ã«é¢ããæœçã®ç·åçãã€èšç»çãªæšé²ã«é¢ããåºæ¬çãªæ¹å 第 2 åœãå°æ¹å ¬å ±å£äœãã®ä»é¢ä¿è ã®äºé²æ¥çš®ã«é¢ãã圹å²åæ ã«é¢ããäºé 第 3 äºé²æ¥çš®ã«é¢ããæœçã®ç·åçãã€èšç»çãªæšé²ã«ä¿ãç®æšã«é¢ããäºé 第 4 äºé²æ¥çš®ã®ã®é©æ£ãªå®æœã«é¢ããæœçãæšé²ããããã®åºæ¬çäºé 第 5 äºé²æ¥çš®ã®ç 究éçºã®æšé²åã³ã¯ã¯ãã³ã®äŸçµŠã®ç¢ºä¿ã«é¢ããæœçãæšé²ããããåºæ¬çäºé 第 6 äºé²æ¥çš®ã®æå¹æ§åã³å®å šæ§ã®åäžã«é¢ããæœçãæšé²ããããã®åºæ¬çäºé 第 7 äºé²æ¥çš®ã«é¢ããåœéçãªé£æºã«é¢ããäºé 第 8 ãã®ä»äºé²æ¥çš®ã«é¢ããæœçã®ç·åçãã€èšç»çãªæšé²ã«é¢ããéèŠäºé åçåŽåçïŒäºé²æ¥çš®åºæ¬èšç»ã®çå®ã«ã€ããŠããæç²
ïŒïŒïŒ äºé²æ¥çš®æ³ http://law.e-gov.go.jp/htmldata/S23/S23HO068.html ïŒïŒïŒ åçåŽåçïŒäºé²æ¥çš®åºæ¬èšç»ã®çå®ã«ã€ã㊠http://www.mhlw.go.jp/topics/2014/01/dl/tp0120-03-04p.pdf
18 T H E VA LU E O F VACC I N ES
æ¥æ¬ã®ã¯ã¯ãã³æ¿çã®å€é·
⌠ä»åŸã®æ¥æ¬ã«ãããã¯ã¯ãã³ã®äŸ¡å€ãšã¯ ãããŸã§ã¿ãŠããããã«ãæ¥æ¬ã§ããããããæ¥
å»çæè¡ã®é²æ©ãé«éœ¢åãªã©ãæ¥æ¬ã®å»çã
YearsïŒãé害調æŽçå幎 (DALYs: Disability
çš®ã§ããã¯ã¯ãã³ã®æ°ããäžçæšæºã«è¿œãã€
åãå·»ãç°å¢ã¯å€§ããå€åããŠããŸããå»ç
Adjusted Life Years) ãããã«åäžããããª
ããŠããŸããããããã ãã¯ããã«ãã§ç€ºãã
ãµãŒãã¹ãåŸæ¥ã®ãæ²»çããããäºé²ããžãšã·
ã©ãæ§ã ãªå»ççµæžè©äŸ¡ææšã§ã¯ã¯ãã³ã®å¹
éå£äºé²å¹æãè²»çšå¯Ÿå¹æãªã©ãé©æ£ãªã¯ã¯
ããããå¥åº·äžã®åé¡ã§å¶éãããã«æ¥åžžç
çšã瀟äŒçµæžçã«è©äŸ¡ããã¯ã¯ãã³æ¥çš®ã®ç€Ÿ
ãã³æ¥çš®ãéæãããã質ãã®é¢ã§ãã¯ã¯ãã³ã»
掻ãéããæéãæããå¥åº·å¯¿åœãã®å»¶é·ã
äŒçãªäŸ¡å€ãããã«é«ããèŠç¹ãå¿ èŠãšãã
ã®ã£ããããç¶ããŠããŸãã
ç®æšãšããããã«ãªããŸãããããã«å¥åº·å¯¿åœ
ãŠããŸãã
ã®äŒžã³ã«ãã£ãŠçããçµæžçãªäŸ¡å€ããå»ç 2013 幎ã®æ³æ¹æ£ä»¥éãå®ææ¥çš®ã®å¯Ÿè±¡ãšãª
è²»ã®è² æ ãäžåãããšãæåŸ ãããŠããŸããã€
åœéåãèããé²ãã çµæãè¡çç°å¢ãšå»ç
ãã¯ã¯ãã³ã®æ°ã¯å¢ããŸããããã ã³ãã¹ïŒã
ãŸããææ°ã®äºé²å»çã«ãã£ãŠç æ°ã«ããã
ç°å¢ãé«åºŠã«æŽåãããæ¥æ¬ã«ãããŠãææ
ããµã颚éªïŒããã¿ãB åèçãªã©å€ãã®å é²
ãªããããã£ãŠãéçåããªãããšããQOLïŒç
çã®è åšã¯ç¡ããªããŸãããæ¢åã®ã¯ã¯ãã³ã®
åœã§å®ææ¥çš®ã«çµã¿å ¥ããããŠããçŸæ£ã«ã€
掻ã®è³ªïŒã®åäžãšå ¬è¡è¡çç°å¢ã®æ¹åãã²ã
æ¥çš®çãé«ãç¶æãããããŠæ°ãã«éçºããã
ããŠã¯ããŸã è°è«åã°ã§ãããŸããå®ææ¥çš®
ãŠã¯å»çè²»åæžã«ãã€ãªãããšèããããŸãã
ã¯ã¯ãã³ã§çŸæ£ã®äºé²ãæŽã«æšé²ããŠããããš
ã§ããã¯ã¯ãã³ãå¢ããããããã被æ¥çš®è ã®
äºé²æ¥çš®ã¯ãã®çé ã«æããããã§ãããã
ãéèŠã§ããæ¥æ¬ã®å»çã¯ä»ã倧ããªè»¢ææ
éé¢ã®è² æ ãæ¥çš®è² æ ãæžãããäºé²æ¥çš®ã¹
ãè¿ããŠããŸãããã€ãããã¯ãªç°å¢ã®å€åã«
ã±ãžã¥ãŒã«ãé©æ£åããããã«ãæ··åã¯ã¯ãã³
ãããŸã§æ¥æ¬ã§ã¯ãè²» çšå¯Ÿå¹æãªã©å»ç çµ
沿ã£ãŠã¯ã¯ãã³ã®äŸ¡å€ãåèªèãã ãã¯ã¯ãã³
ã®å°å ¥ãæ¥ãå¿ èŠããããŸãããã®ã»ããB é¡
æžã®é¢ããã®ã¯ã¯ãã³ã®æçšæ§ã®è©äŸ¡ãäžå
ã§äºé²ã§ããçŸæ£ã¯äºé²ããããšããç念ã
çŸç ã®ããã«è¢«æ¥çš®è ã«è²»çšè² æ ããããã
åã§ãããä»åŸã¯ãäºé²æ¥çš®ã«ãã£ãŠçŸæ£ã®
ãã£ãŠãäºé²æ¥çš®ãæšé²ããŠããããšãæ±ãã
ãããšã®æ¯éããã¯ã¯ãã³ã®æ¥çš®çãããã«æ¹
眹æ£çãã©ãæ¹åãããããæåŸ äœåœã質調
ããŠããã®ã§ãã
åããããªã©ã®èª²é¡ãæ®ãããŠããŸãã
æŽ ç å 幎ïŒQALYs: Quality Adjusted Life
T H E VA LU E O F VACC I N ES 19
ã¯ã¯ãã³ãäžå¿ã«ã äºé²å»åŠã®é²å±ã倧ãã«æåŸ ã§ãã
å²¡éš ä¿¡åœŠ å·åŽåžå®å šç 究ææé· åçç§åŠå¯©è°äŒäºé²æ¥çš®  ã¯ã¯ãã³åç§äŒäŒé·
21 äžçŽã¯äºé²å»åŠã®æ代
ã¯ã¯ãã³æ¥çš®çã®åäžãªã©ããææçãæžå°
å ¬çã«æ¥çš®ããã¯ã¯ãã³ã®çš®é¡ãå°ãªããªããš
ããŠãããšãå人ã®éžæãå°éãããšããæå³
ãããã¯ã¯ãã³ã»ã®ã£ããããåŒãèµ·ãããŠããŸã£
1 äžçŽã¯äºé²å»åŠã®æ代ãšããããŸãã
ãããæãåœã«ãããäºé²æ¥çš®ã¯åŒ·å¶ïŒçŸ©åïŒ
ãã®ã§ãã
ã¯ã¯ãã³ãæèè¬ïŒæçç©è³ªïŒã«ããã
ã§ã¯ãªããªããå§å¥šæ¥çš®ãããªãã¡åãããã
å€ãã®ææçã®çœ¹æ£æ°ãæ¿æžããŠããŸ
ã«åªããåªå矩åãšãªããŸããããŸããäºé²
çŸæ¥å³ éº»ç¹ é¢šç¹ã®æµè¡ãš
ããããããããŠæ²»çãšãšãã«ã¯ã¯ãã³ãªã©ã«
æ¥çš®ãåããããšã«ã€ããŠãã®ææãæãããª
è¿å¹Žã®äºé²æ¥çš®ã®å®æ
ããäºé²ã®åœ¹å²ãèŠçŽãããŠããŸããããšãã°ã
å Žåã«ã¯ãNoããšããããšãã§ããæš©å©ã確
èãããè朰çã¯ããªã³ãã¯ã¿ãŒãããªèã§åŒ
ä¿ãããŸããã
â çŸæ¥å³
ãèµ·ããããããšãæããã«ãããŠãããçŸåšã
ã¯ã¯ãã³ã¯æ¥çš®ãã人ã«å ç«åå¿ãèµ·ãã
çŸæ¥å³ã¯ã¯ãã³ã¯ããžãããªã¢ãç Žå·é¢šãšã®
é€èæ²»çãšäžŠè¡ããŠã¯ã¯ãã³ã«ããææäºé²ã®
ã®ã§ãçäœã«å¯Ÿããå¥åº·è¢«å®³ããŸã£ããã®ãŒã
ïŒçš®æ··åã¯ã¯ãã³ïŒDPT ã¯ã¯ãã³ïŒãã1968
ç 究ãè¡ãããŠããŸãã
ã«ããããšã¯ãæ®å¿µãªããã§ããŸãããããã
幎ã«å®æåãããããåœã¯ïŒã€ã®çŸæ£ã®çœ¹æ£
ãŸããåèçãŠã€ã«ã¹ã¯ã¯ãã³ããããã
ãããæå°ã«ãããããããšãã°ããªãªã®çã¯
çããäžçã§æãäœãåœã«äœçœ®ããããšãã§
ããŒããŠã€ã«ã¹ã¯ã¯ãã³ã¯ãè硬å€ã»èããã
ã¯ãã³ãäžæŽ»åã«ããŠãçããªãªã¯ã¯ãã³ã«ã
ããŸããããããã1975 幎ã«çŸæ¥å³ã¯ã¯ãã³
åå®®é žãããã¿ãŒã²ããã§ããè¿å¹Žã¯ã¯ã¯ãã³
ãçšã«çãã麻çºäŸããŒãã«ãããªã©ãå°ãã§
ã®æåãè³çãåŒãèµ·ãããŠãããããããªã
ã«ããææç以å€ã®çŸæ£ã®äºé²ãè©Šã¿ãããŠ
ããªã¹ã¯ãå°ãªãã¯ã¯ãã³ãéçºããåªåãç©
ãšããæ°äŸã®æ£è ããã確èªããããããæ¥
ãããããçš®ã«ãã£ãŠå ç«ãã¿ãŒã²ãããšãã
ã¿éããããŠããŸããã
çš®ãäžæ¢ãããããšããããŸãããããããäž
ã¯ã¯ãã³ãããªãã¡å ç«åãé«ããããšã«ãã£
ããããå¯åå¿ã®äœæžãšæå¹æ§ãè£è ¹ã®é¢
ææéäžããã³æ°ããªã¯ã¯ãã³ãéçºããã
ãŠãããäºé²ããããæ²»çãããããã¯ã¯ãã³ã
ä¿ã«ããããšããŸããç¥ã£ãŠçœ®ããå¿ èŠããã
åŸãããã°ããã¯å¯åå¿ãèµ·ãããŠããŸã£ã人
ã®éçºç 究ãé²ããããŠããŸããããããã¯ã
ãŸãã
以äžã®æ¹ã ãèªç¶ææãèµ·ãããŠéå·è ã»æ»
ã¯ã¯ãã³ãäžå¿ãšããäºé²å»åŠã®é²å±ã倧ãã«
å¥åº·è¢«å®³ãšããã¯ã¯ãã³ãšåãé¢ããªãå¯å
亡è æ°ãå¢ããããšã«ãªããçŸæ¥å³ã®çºçç¶
æåŸ ãããŸãã
å¿ã®åé¡ãã瀟äŒã®é¢å¿ãéããããšã¯å°ãª
æ³ãäžæ¢åã®ç¶æ ã«æ»ãããã«ã10 幎以äžã
ã¯ã¯ãã³ã«å¯ŸããããŒãºãšä¿¡é ŒåºŠãå€åãã
ããããŸããããã€ãŠã§ããã°ãçš®çã«ããè³
ãã£ãŠããŸããŸããã
第ïŒæ¬¡äžç倧æŠçŽåŸã®ææçãè延ããŠãã
çãã€ã³ãã«ãšã³ã¶ã®éå£æ¥çš®ãMMR ã¯ã¯ã
çŸæ¥å³ã¯ã¯ãã³ã¯ããã®æã«æ¹è¯ããªããã
æ代ã«ã¯ãç®ã®åã®æµè¡ãé²ã人ã ã®åœãæã
ã³ã®åé¡ãªã©ããããããŸãããããã¯äžæ¹ã§
çŸåšåºã䜿çšãããŠããããå¯åå¿ãèµ·ããã«
ããã«ãæãåœã«ãããŠã匷å¶çãªå¶åºŠã®ã
ã¯ãã¯ã¯ãã³ã«ããäºé²ã®ä¿¡é Œãæããæ¥æ¬
ããç¡çŽ°èåã¯ã¯ãã³ãéçºãããŸããããã
ãšã«ã¯ã¯ãã³æ¥çš®ãè¡ãããŠããŸãããããã
å šäœã®äžã§æ°ããªã¯ã¯ãã³å°å ¥ãšããããšã«å¯Ÿ
ãäžæ¹ã§ã¯ãå¹æã®æç¶æ§ã匱ããªããå ç«
çµæžãçºå±ããè¡çç°å¢ãæ¹åãå»åŠã®é²æ©ã
ããŠååãã§ã¯ãªããªããå é²è«žåœãšæ¯èŒããŠ
åãæžåŒ±ããé幎ã»æ人æ£è ãå¢å ã2004
2
20 T H E VA LU E O F VACC I N ES
幎以éã幎é·å°å ãããã¯æ人局ã§ã®çŸæ¥å³
ãã2012 幎ãã 13 幎ã«ãããŠé¢šç¹ã®æµè¡ã
ã«ã€ããŠïŒç¬¬ïŒæ¬¡æèšïŒãããŸãšããŸããããã®
ã®å¢å ãäºé²æ¥çš®çã®é«ãåœã ã«ãããŠå ±é
åé¡ãšãªããŸããã颚ç¹ã¯ã¯ãã³ãå®ææ¥çš®ãš
ç®çã¯ãã¯ã¯ãã³ã»ã®ã£ããã«å¯Ÿå¿ããäºé²æ¥
ã®èª²é¡ãšãªã£ãŠããŠããŸãããããŠæ人çŸæ¥å³
ããŠåããããšããªãã£ãæ代ã«æé·ããç·æ§
çš®æœçãäžé·æçãªèŠ³ç¹ããç·åçã«è©äŸ¡ 
ããDPT æ¥çš®åã®ä¹³å ãžã®æææºã«ãªããšã
ãå ç«ãæããªããŸãŸå€§äººãšãªãããããžæ±ã¢
æ€èšããäœå¶ãã€ããããšã§ãããããŠãå»åŠ
ããæ°ããªåé¡ãçºçããŠããŸãã
ãžã¢ã§æµè¡ããŠãã颚ç¹ãŠã€ã«ã¹ãæã¡èŸŒãŸ
ç芳ç¹ãããåºãæ¥çš®ãé²ããªããã°ãªããª
â¡ éº»ç¹ 2007 幎ã«ã¯ãå šåœã®é«æ ¡ã倧åŠã§éº»ç¹ã æµè¡ãäŒæ ¡ãçžæ¬¡ããŸãããèæ¯ã«ã¯ãå°åŠ ç以äžã§ã®éº»ç¹ã®æµè¡ãæžã£ãäžæ¹ãäºé²æ¥ çš®ãåããªããŸãŸææãããã«æé·ããé«æ ¡
çŸåšã§ã¯åœå ã§æµè¡ããŠãã麻ç¹ãŠã€ã«ã¹ã¯ æ¶ãå»ããŸããããæµ·å€ããæã¡èŸŒãŸããããšãããã æ¥æ¬ã¯éº»ç¹èŒžåºåœã§ã¯ãªããèŒžå ¥åœåŽãšãªããŸããã
çã»å€§åŠçãå¢ããããšãäžã«ã¯äºé²æ¥çš®ã åããŠããå ç«ãç²åŸã§ããªãã£ã人ãå°æ° ããããšãäºé²æ¥çš®ã«ãã£ãŠæäœãã§ãããã®
ãããããå ç«ãæã£ãŠããªãç·æ§ã«ææãã
ãã¯ã¯ãã³ãšããŠãåå®®é žãããHibãå°å çš
ã®ãèªç¶ææã«ããåºæ¿ïŒããŒã¹ã¿ãŒïŒã®æ©äŒ
ãããæææºãæµè¡æºãšãªããå²åãšããŠã¯ç·
èºççèãæ°Žçããããµããããæ人çšèºç
ãäœäžããŠãããããæäœäŸ¡ãçºç ãé»æ¢ã
æ§ããå°æ°ã§ããå ç«ãæã£ãŠããªã女æ§ã«
çèãåèçã®ïŒã¯ã¯ãã³ããããŠããŸãã
ãã¬ãã«ä»¥äžã«ãªã£ãŠããŸã£ã人ãããããšã
ãææãåãã§ããŸã£ãããã§ãã
ãŸããã¿ã«ã€ããŠã¯ãæ©æ¥ã«å°é家ã«ããè©äŸ¡
ãããŸããããããžéº»ç¹ãŠã€ã«ã¹ãããããã¿
åŠåš åæã®å¥³æ§ã颚ç¹ãŠã€ã«ã¹ã«ææãã
ãè¡ãããæ瀺ãã ããŠããŸãã
ãŠå ¥ã蟌ãã§ããã®ã§ããåœæããããã®äžã«
ãšãèå ã«ææãããã³ãå 倩æ§é¢šç¹çå矀
ãã®æèšãåãã2013 幎ïŒæã«äºé²æ¥çš®æ³
ã¯éº»ç¹ã®æžå°ã«æåããŠããåœãæ è¡äžã«çº
ïŒäž»ã«çŒã»è³ã»å¿èãªã©ã«é害ãåºçŸããïŒã®
çããäŸãªã©ãçžæ¬¡ããæ¥æ¬ã¯ã麻ç¹ã®èŒžåºåœã
èµ€ã¡ãããçãŸããå±éºæ§ãé«ãŸããŸããæ®å¿µ
ãªã©ãšèšãããããšããããŸããã
ãªããã2011-13 幎ã®æ人ã§ã®é¢šç¹ã®æµè¡ã«
åçåŽåçã¯ã2007 幎ã«éº»ç¹ã«é¢ããç¹
ãããå 倩æ§é¢šç¹çå矀å ãå¢å ããŠããŸã
å®ææçäºé²æéãçºè¡šãïŒåæ¥çš®ã培åºãã
ãŸãããåŠåš äžã§ã¯ãªããŠãå ç«ãæã£ãŠããª
ããã« 5 幎éããããŠäžåŠïŒå¹Žçãé«æ ¡ïŒå¹Ž
ã女æ§ãåŠå©Šã®å®¶æãè·å Žã®ååã¯ãææã
ççžåœã®å¹Žéœ¢å±€ã«ãã¯ã¯ãã³ïŒéº»ç¹ïŒé¢šç¹ïŒæ¥
é²ããã麻ç¹é¢šç¹æ··åã¯ã¯ãã³ïŒMR ã¯ã¯ãã³ïŒ
çš®ãè¡ãäœå¶ãæŽããŸããã2008 幎ããã¯
ã®æ¥çš®ãæãŸããŸãã
äžåŠïŒå¹Žãé«æ ¡ïŒå¹Žçžåœå¹Žéœ¢ã®è ã«å®ææ¥çš® ãè¡ãããšãšãã1990 幎以éã«çãŸãã人ã¯ã å šãŠïŒåæ¥çš®ã®æ©äŒãããããã«ãªããåœå ã®éº»ç¹ã¯æ¿æžããŸããã çŸåšã§ã¯åœå ã§æµè¡ããŠãã麻ç¹ãŠã€ã«ã¹ ã¯æ¶ãå»ããŸããããæµ·å€ããæã¡èŸŒãŸããã ãšããããæ¥æ¬ã¯éº»ç¹èŒžåºåœã§ã¯ãªããèŒžå ¥
ãæ¹æ£ãããŸãããäž»ãªå 容ã¯ã以äžã§ãã 1. äºé² æ¥ çš®ã®ç·å çãªæš é²ãå³ãããã® èšç»ãçå®ããïŒå¹Žã«äžåºŠèŠçŽããããã 2. Hib ã¯ã¯ãã³ãå°å çšèºççèã¯ã¯ãã³ã åå®®é žããã¯ã¯ãã³ã®å®ææ¥çš®åãããã 3. å¯åå¿å ±åå¶åºŠ  è©äŸ¡å¶åºŠã®åŒ·åãšå¯å å¿å ±åã®æ³å®åãšãµãŒãã€ã©ã³ã¹ã®åŒ·åã ã¯ããã
æ°ããæ代ãè¿ããŠããäºé²æ¥çš®å¶åºŠ
4. å®æçã»äžæçå±å¢ã«ç«ã£ãäºé²æ¥çš®ã« é¢ããè©äŸ¡  æ€èšçµç¹ãèšç«ããã
ã¯
ã¯ãã³ã®å¯åå¿ãç¡èŠãããããªã ã¡å¯åå¿ã¯ãããããããšããããã¯
ããã«åºã¥ãã圢ã§äºé²æ¥çš®æ³ãæ¹æ£ã
ãšã¯ã¯ãã³ãšã¯é¢ä¿ã®ãªããããªããšã
ããã¯ã¯ãã³ã»ã®ã£ããã解æ¶ããäœå¶ãæŽã£
ãšçä»ããŠããŸã£ãŠã¯çã®äºé²çãšã¯ãªããŸã
ããšãããŸããä»åŸã¯ããã«çžå¿ããéçšã
åœåŽãšãªããŸãããä»åŸã¯ãããããã£ããã«
ããå šäœã«ã ãç®ãè¡ãå人ãèŠæšãŠãŠããŸã
æ±ããããŸããã¯ã¯ãã³æ¥çš®ã®å®æœæ³ãè©äŸ¡
åœå ã§æµ·å€æµè¡ã®ãŠã€ã«ã¹ã®æ¡å€§ãé»æ¢ãã
ããšã¯ããã©ã³ã¹ãæ¬ ããŠããããšã«ãªããŸãã
æ³ãªã©ã§ã®è³ªçãªé¢ã§ã®åäžãæ±ããããŠã
å¿ èŠããããå€ãã®äººããã¡ããšå®ææ¥çš®ã¯ã¯
ãŸãå察ã«ãäžäººã²ãšãã®ãªã¹ã¯ãé倧è©äŸ¡ã
ãŸãããã®ããã«ããïŒã€ã®ã¯ã¯ãã³æ¿çã«ãã£
ãã³ãåããŠããããšãå§ããããŸãã
ãŠãå šäœã«åž°ããããã§ã¯çå€ããšãªã£ãŠããŸ
ãŠçãããããã£ãããšãªã¹ã¯ãç§åŠçã«å®é
ããŸããçŸæç¹ã§ã®ãã©ã³ã¹ãçèãæè¯ã®å¯Ÿ
åããããã®æ å ±åéãäœããã倧åãªãã®
⢠颚ç¹
çãéžæããããšãåžžã«æ±ããããŸãã
ã«ãªããšèããŠããŸãã
麻ç¹ã»é¢šç¹ã¯ã¯ãã³ïŒMR ã¯ã¯ãã³ïŒã®æ®å
2012 幎ïŒæãåçç§åŠå¯©è°äŒææçåç§
ã«ãããåœå ã§ã¯äžåºŠã»ãŒåãŸã£ã颚ç¹ã§ã
äŒäºé²æ¥çš®éšäŒã¯ã ãäºé²æ¥çš®å¶åºŠã®èŠçŽã
T H E VA LU E O F VACC I N ES 21
THE
VA L U E OF
VA C C I N E S
22 T H E VA LU E O F VACC I N ES
T H E VA LU E O F VACC I N ES 23
ç±³åœç 究補è¬å·¥æ¥åäŒ ã 105-0001 æ±äº¬éœæž¯åºèãé 3-7-8 ã©ã³ãã£ãã¯ç¬¬ 2 èãéãã« 4 é TEL. 03-5408-1061 FAX. 03-5408-1062
www.phrma-jp.org
24 T H E VA LU E O F VACC I N ES